Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MetFinder: A Tool for Automated Quantitation of Metastatic Burden in Histological Sections From Preclinical Models.
Karz A, Coudray N, Bayraktar E, Galbraith K, Jour G, Shadaloey AAS, Eskow N, Rubanov A, Navarro M, Moubarak R, Baptiste G, Levinson G, Mezzano V, Alu M, Loomis C, Lima D, Rubens A, Jilaveanu L, Tsirigos A, Hernando E. Karz A, et al. Among authors: galbraith k. Pigment Cell Melanoma Res. 2025 Jan;38(1):e13195. doi: 10.1111/pcmr.13195. Epub 2024 Sep 10. Pigment Cell Melanoma Res. 2025. PMID: 39254030
Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors.
Galbraith K, Serrano J, Shen G, Tran I, Slocum CC, Ketchum C, Abdullaev Z, Turakulov R, Bale T, Ladanyi M, Sukhadia P, Zaidinski M, Mullaney K, DiNapoli S, Liechty BL, Barbaro M, Allen JC, Gardner SL, Wisoff J, Harter D, Hidalgo ET, Golfinos JG, Orringer DA, Aldape K, Benhamida J, Wrzeszczynski KO, Jour G, Snuderl M. Galbraith K, et al. Mol Cancer Res. 2024 Jan 2;22(1):21-28. doi: 10.1158/1541-7786.MCR-23-0627. Mol Cancer Res. 2024. PMID: 37870438 Free PMC article.
Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing.
Galbraith K, Vasudevaraja V, Serrano J, Shen G, Tran I, Abdallat N, Wen M, Patel S, Movahed-Ezazi M, Faustin A, Spino-Keeton M, Roberts LG, Maloku E, Drexler SA, Liechty BL, Pisapia D, Krasnozhen-Ratush O, Rosenblum M, Shroff S, Boué DR, Davidson C, Mao Q, Suchi M, North P, Hopp A, Segura A, Jarzembowski JA, Parsons L, Johnson MD, Mobley B, Samore W, McGuone D, Gopal PP, Canoll PD, Horbinski C, Fullmer JM, Farooqui MS, Gokden M, Wadhwani NR, Richardson TE, Umphlett M, Tsankova NM, DeWitt JC, Sen C, Placantonakis DG, Pacione D, Wisoff JH, Teresa Hidalgo E, Harter D, William CM, Cordova C, Kurz SC, Barbaro M, Orringer DA, Karajannis MA, Sulman EP, Gardner SL, Zagzag D, Tsirigos A, Allen JC, Golfinos JG, Snuderl M. Galbraith K, et al. Neurooncol Adv. 2023 Jun 26;5(1):vdad076. doi: 10.1093/noajnl/vdad076. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37476329 Free PMC article.
DNA methylation as a diagnostic tool.
Galbraith K, Snuderl M. Galbraith K, et al. Acta Neuropathol Commun. 2022 May 8;10(1):71. doi: 10.1186/s40478-022-01371-2. Acta Neuropathol Commun. 2022. PMID: 35527288 Free PMC article. Review.
Deep learning-based classifier for carcinoma of unknown primary using methylation quantitative trait loci.
Walker A, Fang CS, Schroff C, Serrano J, Vasudevaraja V, Yang Y, Belakhoua S, Faustin A, William CM, Zagzag D, Chiang S, Acosta AM, Movahed-Ezazi M, Park K, Moreira AL, Darvishian F, Galbraith K, Snuderl M. Walker A, et al. Among authors: galbraith k. J Neuropathol Exp Neurol. 2024 Nov 28:nlae123. doi: 10.1093/jnen/nlae123. Online ahead of print. J Neuropathol Exp Neurol. 2024. PMID: 39607989
DNA Methylation Profiling in Rare Sellar Tumors.
Wright K, Galbraith K, Snuderl M, Agrawal N. Wright K, et al. Among authors: galbraith k. Biomedicines. 2022 Sep 8;10(9):2225. doi: 10.3390/biomedicines10092225. Biomedicines. 2022. PMID: 36140326 Free PMC article.
Anaplastic Transformation in Myxopapillary Ependymoma: A Report of 2 Cases and Review of the Literature.
Gitto L, Serinelli S, Galbraith K, Williams M, Mirchia K, Galgano MA, Krishnamurthy S, de la Roza G, Viapiano MS, Walker JM, Jour G, Serrano J, DeLorenzo M, Snuderl M, Richardson TE. Gitto L, et al. Among authors: galbraith k. J Neuropathol Exp Neurol. 2020 Oct 1;79(10):1044-1053. doi: 10.1093/jnen/nlaa077. J Neuropathol Exp Neurol. 2020. PMID: 32743660 Review.
Racial distribution of molecularly classified brain tumors.
Fang CS, Wang W, Schroff C, Movahed-Ezazi M, Vasudevaraja V, Serrano J, Sulman EP, Golfinos JG, Orringer D, Galbraith K, Feng Y, Snuderl M. Fang CS, et al. Among authors: galbraith k. Neurooncol Adv. 2024 Aug 2;6(1):vdae135. doi: 10.1093/noajnl/vdae135. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 39220243 Free PMC article.
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas.
Galbraith K, Garcia M, Wei S, Chen A, Schroff C, Serrano J, Pacione D, Placantonakis DG, William CM, Faustin A, Zagzag D, Barbaro M, Eibl MDPGP, Shirahata M, Reuss D, Tran QT, Alom Z, von Deimling A, Orr BA, Sulman EP, Golfinos JG, Orringer DA, Jain R, Lieberman E, Feng Y, Snuderl M. Galbraith K, et al. Neuro Oncol. 2024 Jun 3;26(6):1042-1051. doi: 10.1093/neuonc/noae009. Neuro Oncol. 2024. PMID: 38243818
151 results